SEC Form 4 · accession 0001424422-19-000003
BioPharmX Corp · BPMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald Todd Plott
Director
Period of report
Feb 1, 2019
Accepted (ET)
Feb 21, 2019 · 6:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001504167
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase common stockF1 | $0.11 | Feb 1, 2019 | A | 133,000 | A | Mar 1, 2019 | Feb 1, 2029 | Common stock | 133,000 | 133,000 | D |
| Option to purchase common stockF2 | $0.11 | Feb 1, 2019 | A | 200,000 | A | Mar 1, 2019 | Feb 1, 2029 | Common stock | 200,000 | 333,000 | D |
| Option to purchase common stockF1 | $0.20 | Feb 1, 2019 | A | 34,000 | A | Mar 1, 2019 | Feb 1, 2029 | Common stock | 34,000 | 367,000 | D |
| Option to purchase common stockF2 | $0.20 | Feb 1, 2019 | A | 51,000 | A | Mar 1, 2019 | Feb 1, 2029 | Common stock | 51,000 | 418,000 | D |
Explanation of responses
- F1This option vests ratably over 4 months with the first vesting starting on 3/1/2019.
- F2This option vests ratably over 24 months with the first vesting starting on 3/1/2019.